Age of clinical onset of the MCI and dementia converters did not significantly differ between APOE e2+ and e2− genotypes, but the trends were in the hypothesized direction such that APOE e2+ mutation carriers had on average later clinical onset (Supplementary Table 1). The gene discussed is APOE; the disease is dementia.